vs

Side-by-side financial comparison of CORE MOLDING TECHNOLOGIES INC (CMT) and TACTILE SYSTEMS TECHNOLOGY INC (TCMD). Click either name above to swap in a different company.

TACTILE SYSTEMS TECHNOLOGY INC is the larger business by last-quarter revenue ($103.6M vs $74.7M, roughly 1.4× CORE MOLDING TECHNOLOGIES INC). On growth, TACTILE SYSTEMS TECHNOLOGY INC posted the faster year-over-year revenue change (21.0% vs 19.5%). TACTILE SYSTEMS TECHNOLOGY INC produced more free cash flow last quarter ($16.8M vs $-2.9M). Over the past eight quarters, TACTILE SYSTEMS TECHNOLOGY INC's revenue compounded faster (30.2% CAGR vs -2.2%).

Core Molding Technologies, Inc. was founded in 1988 and now based in Columbus, Ohio. The company manufactures sheet molding compounds (SMC), and molds fiberglass reinforced plastics. It occupies over 1,000,000 square feet of manufacturing space and its main subsidiaries are in Matamoros, Mexico, Gaffney, South Carolina, and Cincinnati, Ohio. In 2011, Core Molding Technologies formed Core Specialty Composites, LLC.

Dominion Voting Systems Corporation was a North American company that produced and sold electronic voting hardware and software, including voting machines and tabulators, in Canada and the United States.

CMT vs TCMD — Head-to-Head

Bigger by revenue
TCMD
TCMD
1.4× larger
TCMD
$103.6M
$74.7M
CMT
Growing faster (revenue YoY)
TCMD
TCMD
+1.6% gap
TCMD
21.0%
19.5%
CMT
More free cash flow
TCMD
TCMD
$19.7M more FCF
TCMD
$16.8M
$-2.9M
CMT
Faster 2-yr revenue CAGR
TCMD
TCMD
Annualised
TCMD
30.2%
-2.2%
CMT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CMT
CMT
TCMD
TCMD
Revenue
$74.7M
$103.6M
Net Profit
$10.6M
Gross Margin
15.2%
78.2%
Operating Margin
4.8%
18.1%
Net Margin
10.3%
Revenue YoY
19.5%
21.0%
Net Profit YoY
9.4%
EPS (diluted)
$0.35
$0.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMT
CMT
TCMD
TCMD
Q4 25
$74.7M
$103.6M
Q3 25
$58.4M
$85.8M
Q2 25
$79.2M
$78.9M
Q1 25
$61.4M
$61.3M
Q4 24
$62.5M
$85.6M
Q3 24
$73.0M
$73.1M
Q2 24
$88.7M
$73.2M
Q1 24
$78.1M
$61.1M
Net Profit
CMT
CMT
TCMD
TCMD
Q4 25
$10.6M
Q3 25
$1.9M
$8.2M
Q2 25
$4.1M
$3.2M
Q1 25
$2.2M
$-3.0M
Q4 24
$9.7M
Q3 24
$3.2M
$5.2M
Q2 24
$6.4M
$4.3M
Q1 24
$3.8M
$-2.2M
Gross Margin
CMT
CMT
TCMD
TCMD
Q4 25
15.2%
78.2%
Q3 25
17.4%
75.8%
Q2 25
18.1%
74.5%
Q1 25
19.2%
74.0%
Q4 24
15.8%
75.2%
Q3 24
16.9%
75.0%
Q2 24
20.0%
73.9%
Q1 24
17.0%
71.1%
Operating Margin
CMT
CMT
TCMD
TCMD
Q4 25
4.8%
18.1%
Q3 25
4.4%
12.8%
Q2 25
6.6%
5.2%
Q1 25
4.6%
-7.4%
Q4 24
1.4%
14.6%
Q3 24
4.9%
9.3%
Q2 24
8.4%
8.0%
Q1 24
6.1%
-4.9%
Net Margin
CMT
CMT
TCMD
TCMD
Q4 25
10.3%
Q3 25
3.2%
9.6%
Q2 25
5.1%
4.1%
Q1 25
3.6%
-4.9%
Q4 24
11.4%
Q3 24
4.3%
7.1%
Q2 24
7.2%
5.9%
Q1 24
4.8%
-3.6%
EPS (diluted)
CMT
CMT
TCMD
TCMD
Q4 25
$0.35
$0.45
Q3 25
$0.22
$0.36
Q2 25
$0.47
$0.14
Q1 25
$0.25
$-0.13
Q4 24
$-0.01
$0.40
Q3 24
$0.36
$0.21
Q2 24
$0.73
$0.18
Q1 24
$0.43
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMT
CMT
TCMD
TCMD
Cash + ST InvestmentsLiquidity on hand
$38.1M
$83.4M
Total DebtLower is stronger
$17.6M
$0
Stockholders' EquityBook value
$158.2M
$218.9M
Total Assets
$228.1M
$273.9M
Debt / EquityLower = less leverage
0.11×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMT
CMT
TCMD
TCMD
Q4 25
$38.1M
$83.4M
Q3 25
$42.4M
$66.0M
Q2 25
$43.2M
$81.5M
Q1 25
$44.5M
$83.6M
Q4 24
$41.8M
$94.4M
Q3 24
$42.3M
$82.1M
Q2 24
$37.8M
$73.6M
Q1 24
$26.6M
$60.7M
Total Debt
CMT
CMT
TCMD
TCMD
Q4 25
$17.6M
$0
Q3 25
$18.2M
$0
Q2 25
$18.8M
Q1 25
$19.2M
Q4 24
$19.7M
Q3 24
$20.2M
$27.0M
Q2 24
$20.6M
$27.8M
Q1 24
$21.1M
$28.5M
Stockholders' Equity
CMT
CMT
TCMD
TCMD
Q4 25
$158.2M
$218.9M
Q3 25
$155.4M
$204.9M
Q2 25
$153.5M
$194.9M
Q1 25
$149.9M
$205.6M
Q4 24
$147.4M
$216.6M
Q3 24
$147.8M
$207.9M
Q2 24
$147.5M
$200.7M
Q1 24
$142.8M
$193.5M
Total Assets
CMT
CMT
TCMD
TCMD
Q4 25
$228.1M
$273.9M
Q3 25
$219.7M
$259.2M
Q2 25
$219.9M
$273.0M
Q1 25
$223.6M
$280.2M
Q4 24
$209.6M
$297.9M
Q3 24
$220.7M
$287.7M
Q2 24
$225.7M
$278.8M
Q1 24
$212.3M
$272.0M
Debt / Equity
CMT
CMT
TCMD
TCMD
Q4 25
0.11×
0.00×
Q3 25
0.12×
0.00×
Q2 25
0.12×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.14×
0.13×
Q2 24
0.14×
0.14×
Q1 24
0.15×
0.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMT
CMT
TCMD
TCMD
Operating Cash FlowLast quarter
$5.0M
$17.3M
Free Cash FlowOCF − Capex
$-2.9M
$16.8M
FCF MarginFCF / Revenue
-3.9%
16.2%
Capex IntensityCapex / Revenue
10.7%
0.5%
Cash ConversionOCF / Net Profit
1.63×
TTM Free Cash FlowTrailing 4 quarters
$1.9M
$40.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMT
CMT
TCMD
TCMD
Q4 25
$5.0M
$17.3M
Q3 25
$4.6M
$10.3M
Q2 25
$3.5M
$14.8M
Q1 25
$6.1M
$417.0K
Q4 24
$5.0M
$16.3M
Q3 24
$9.2M
$10.3M
Q2 24
$15.9M
$13.1M
Q1 24
$5.1M
$924.0K
Free Cash Flow
CMT
CMT
TCMD
TCMD
Q4 25
$-2.9M
$16.8M
Q3 25
$-346.0K
$9.2M
Q2 25
$880.0K
$14.4M
Q1 25
$4.3M
$38.0K
Q4 24
$509.0K
$15.9M
Q3 24
$7.0M
$9.3M
Q2 24
$13.0M
$12.6M
Q1 24
$3.2M
$442.0K
FCF Margin
CMT
CMT
TCMD
TCMD
Q4 25
-3.9%
16.2%
Q3 25
-0.6%
10.8%
Q2 25
1.1%
18.2%
Q1 25
7.0%
0.1%
Q4 24
0.8%
18.5%
Q3 24
9.6%
12.7%
Q2 24
14.6%
17.3%
Q1 24
4.1%
0.7%
Capex Intensity
CMT
CMT
TCMD
TCMD
Q4 25
10.7%
0.5%
Q3 25
8.4%
1.3%
Q2 25
3.3%
0.5%
Q1 25
2.9%
0.6%
Q4 24
7.2%
0.5%
Q3 24
3.1%
1.3%
Q2 24
3.3%
0.7%
Q1 24
2.4%
0.8%
Cash Conversion
CMT
CMT
TCMD
TCMD
Q4 25
1.63×
Q3 25
2.44×
1.26×
Q2 25
0.86×
4.59×
Q1 25
2.79×
Q4 24
1.68×
Q3 24
2.92×
1.99×
Q2 24
2.47×
3.06×
Q1 24
1.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMT
CMT

Segment breakdown not available.

TCMD
TCMD

Private Insurers$57.6M56%
Medicare$24.6M24%
Durable Medical Equipment Distributors$14.1M14%
Veterans Administration$7.3M7%

Related Comparisons